China Expert

Skystar Bio-Pharmaceutical: Significantly Undervalued

A cash generator and value stock in the most "detailed" interpretation. The company generated $9.7M of EBITDA for the cumulative last twelve months and assuming $19M of net cash generated from the last raise at $12.80 per share, you can buy the whole company for $22.3M (net of cash/debt). I can't find a company in China or in the USA that is valued at less than 2.5x EBITDA, with such nice cash flow margins and that requires so little in capital expenditures to run the business. Can anyone top this value in any company out there ?